Amphiphysin 2 (BIN1) in physiology and diseases I Prokic, BS Cowling, J Laporte Journal of molecular medicine 92, 453-463, 2014 | 182 | 2014 |
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy J Schessl, Y Zou, MJ McGrath, BS Cowling, B Maiti, SS Chin, C Sewry, ... The Journal of clinical investigation 118 (3), 904-912, 2008 | 165 | 2008 |
Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly MJ McGrath, DL Cottle, MA Nguyen, JM Dyson, ID Coghill, PA Robinson, ... Journal of Biological Chemistry 281 (11), 7666-7683, 2006 | 164 | 2006 |
The caveolin–cavin system plays a conserved and critical role in mechanoprotection of skeletal muscle HP Lo, SJ Nixon, TE Hall, BS Cowling, C Ferguson, GP Morgan, ... Journal of Cell Biology 210 (5), 833-849, 2015 | 161 | 2015 |
Reciprocal effects on neurocognitive and metabolic phenotypes in mouse models of 16p11. 2 deletion and duplication syndromes T Arbogast, AM Ouagazzal, C Chevalier, M Kopanitsa, N Afinowi, ... PLoS genetics 12 (2), e1005709, 2016 | 155 | 2016 |
Reducing dynamin 2 expression rescues X-linked centronuclear myopathy BS Cowling, T Chevremont, I Prokic, C Kretz, A Ferry, C Coirault, ... The Journal of clinical investigation 124 (3), 1350-1363, 2014 | 154 | 2014 |
Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy BS Cowling, MJ McGrath, MA Nguyen, DL Cottle, AJ Kee, S Brown, ... Journal of Cell Biology 183 (6), 1033-1048, 2008 | 151 | 2008 |
Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies A Toussaint, BS Cowling, K Hnia, M Mohr, A Oldfors, Y Schwab, U Yis, ... Acta neuropathologica 121, 253-266, 2011 | 145 | 2011 |
Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness BS Cowling, A Toussaint, L Amoasii, P Koebel, A Ferry, L Davignon, ... The American journal of pathology 178 (5), 2224-2235, 2011 | 111 | 2011 |
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice H Tasfaout, S Buono, S Guo, C Kretz, N Messaddeq, S Booten, ... Nature Communications 8 (1), 15661, 2017 | 97 | 2017 |
Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features BS Cowling, DL Cottle, BR Wilding, CE D’Arcy, CA Mitchell, MJ McGrath Neuromuscular Disorders 21 (4), 237-251, 2011 | 93 | 2011 |
Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation BS Cowling, I Prokic, H Tasfaout, A Rabai, F Humbert, B Rinaldi, AS Nicot, ... The Journal of clinical investigation 127 (12), 4477-4487, 2017 | 86 | 2017 |
Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo L Amoasii, K Hnia, G Chicanne, A Brech, BS Cowling, MM Müller, ... Journal of cell science 126 (8), 1806-1819, 2013 | 81 | 2013 |
Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy J Böhm, N Vasli, M Maurer, B Cowling, GD Shelton, W Kress, A Toussaint, ... PLoS genetics 9 (6), e1003430, 2013 | 80 | 2013 |
Defective membrane remodeling in neuromuscular diseases: insights from animal models BS Cowling, A Toussaint, J Muller, J Laporte PLoS genetics 8 (4), e1002595, 2012 | 71 | 2012 |
FHL3 binds MyoD and negatively regulates myotube formation DL Cottle, MJ McGrath, BS Cowling, ID Coghill, S Brown, CA Mitchell Journal of cell science 120 (8), 1423-1435, 2007 | 71 | 2007 |
WANTED–Dead or alive: Myotubularins, a large disease-associated protein family MA Raess, S Friant, BS Cowling, J Laporte Advances in biological regulation 63, 49-58, 2017 | 70 | 2017 |
Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice L Amoasii, DL Bertazzi, H Tronchère, K Hnia, G Chicanne, B Rinaldi, ... Public Library of Science 8 (10), e1002965, 2012 | 67 | 2012 |
Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer MJ McGrath, LC Binge, A Sriratana, H Wang, PA Robinson, D Pook, ... Cancer research 73 (16), 5066-5079, 2013 | 66 | 2013 |
Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy S Buono, JA Ross, H Tasfaout, Y Levy, C Kretz, L Tayefeh, J Matson, ... Proceedings of the National Academy of Sciences 115 (43), 11066-11071, 2018 | 64 | 2018 |